# A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers

> **NCT07162441** · PHASE1 · RECRUITING · sponsor: **Korea United Pharm. Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** treatment A
- **DRUG:** treatment B
- **DRUG:** treatment C

## Key facts

- **NCT ID:** NCT07162441
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-12
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-03-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162441, "A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07162441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*